During the past decade, Central Texas Clinical Research conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 29 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Texas Clinical Research" #1 sponsor was "Gilead Sciences" with 31 trials, followed by "AstraZeneca" with 3 trials sponsored, "Theratechnologies" with 3 trials sponsored, "Alexion" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Texas Clinical Research" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Bellos, Nicholaos C., M.D." with 1 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Central Texas Clinical Research" are "HIV Infections" (19 trials), "HIV-1 Infection" (15 trials), "HIV" (6 trials), "HIV-1-infection" (5 trials) and "Acquired Immunodeficiency Syndrome" (3 trials). Many other conditions were trialed in "Central Texas Clinical Research" in a lesser frequency.

Most popular intervention types in "Central Texas Clinical Research" are "Drug" (66 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "B/F/TAF" (6 trials), "E/C/F/TAF" (6 trials), "Efavirenz" (4 trials) and "F/TAF" (4 trials). Other intervention names were less common.

The vast majority of trials in "Central Texas Clinical Research" are 73 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Central Texas Clinical Research". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 53 completed trials in Central Texas Clinical Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Central Texas Clinical Research, 7 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".